FOLH1 and neoplasm: Then, the authors designed and synthesized TG-10, which contains a cleavable serine-glycine capping group to trigger the selective cleavage of MMAAC and a PSMA-targeting peptide sequence for tumor targeting, as a proof-of-concept study.